You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
McKinsey
Mallinckrodt
Baxter
Colorcon

Last Updated: February 28, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MINOCYCLINE HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Minocycline Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00029874 Minocycline in Patients With Huntington's Disease Completed FDA Office of Orphan Products Development Phase 1/Phase 2 2001-09-01 This is a study to determine whether treatment with minocycline is safe and tolerable in patients with Huntington's disease (HD) and whether minocycline reduces symptoms of HD in these patients.
NCT00047723 Minocycline to Treat Amyotrophic Lateral Sclerosis Completed National Institute of Neurological Disorders and Stroke (NINDS) Phase 3 2003-01-01 The purpose of this trial is to test the safety, tolerability, and effectiveness of minocycline compared to placebo in patients with amyotrophic lateral sclerosis (ALS).
NCT00063193 National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial Completed National Institute of Neurological Disorders and Stroke (NINDS) Phase 2 2003-05-01 The goal of this study is to assess the impact of minocycline and creatine on the progression of Parkinson's disease, in order to determine whether it is reasonable to proceed with further study of either of these agents.
NCT00063193 National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial Completed University of Rochester Phase 2 2003-05-01 The goal of this study is to assess the impact of minocycline and creatine on the progression of Parkinson's disease, in order to determine whether it is reasonable to proceed with further study of either of these agents.
NCT00145106 Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris Completed Allergan Phase 4 2002-03-01 The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
NCT00145106 Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris Completed Jefferson Medical College of Thomas Jefferson University Phase 4 2002-03-01 The purpose of the study is to compare the efficacy of three maintenance regimens (topical tazarotene, oral minocycline, or both) in sustaining improvement in acne.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Minocycline Hydrochloride

Condition Name

Condition Name for Minocycline Hydrochloride
Intervention Trials
Acne Vulgaris 13
Schizophrenia 12
Healthy 5
Papulopustular Rosacea 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Minocycline Hydrochloride
Intervention Trials
Depressive Disorder 14
Depression 14
Schizophrenia 14
Acne Vulgaris 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Minocycline Hydrochloride

Trials by Country

Trials by Country for Minocycline Hydrochloride
Location Trials
United States 393
Canada 24
Germany 13
Israel 10
Pakistan 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Minocycline Hydrochloride
Location Trials
Texas 31
New York 26
California 26
North Carolina 21
Florida 19
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Minocycline Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Minocycline Hydrochloride
Clinical Trial Phase Trials
Phase 4 34
Phase 3 34
Phase 2/Phase 3 4
[disabled in preview] 103
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Minocycline Hydrochloride
Clinical Trial Phase Trials
Completed 75
Recruiting 49
Not yet recruiting 26
[disabled in preview] 56
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Minocycline Hydrochloride

Sponsor Name

Sponsor Name for Minocycline Hydrochloride
Sponsor Trials
M.D. Anderson Cancer Center 13
Foamix Ltd. 12
National Cancer Institute (NCI) 11
[disabled in preview] 18
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Minocycline Hydrochloride
Sponsor Trials
Other 284
Industry 67
NIH 31
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Colorcon
McKinsey
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.